BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24190543)

  • 1. Chronic treatment with olanzapine increases adiposity by changing fuel substrate and causes desensitization of the acute metabolic side effects.
    Girault EM; Guigas B; Alkemade A; Foppen E; Ackermans MT; la Fleur SE; Fliers E; Kalsbeek A
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Feb; 387(2):185-95. PubMed ID: 24190543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.
    Fell MJ; Anjum N; Dickinson K; Marshall KM; Peltola LM; Vickers S; Cheetham S; Neill JC
    Psychopharmacology (Berl); 2007 Oct; 194(2):221-31. PubMed ID: 17581744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of the adverse effects of olanzapine on lipid metabolism with the antiepileptic zonisamide.
    Stefanidis A; Watt MJ; Cowley MA; Oldfield BJ
    Neuropharmacology; 2017 Sep; 123():55-66. PubMed ID: 28400260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early perturbation in feeding behaviour and energy homeostasy in olanzapine-treated rats.
    Victoriano M; Hermier D; Even PC; Fromentin G; Huneau JF; Tomé D; de Beaurepaire R
    Psychopharmacology (Berl); 2009 Sep; 206(1):167-76. PubMed ID: 19572122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis.
    Albaugh VL; Judson JG; She P; Lang CH; Maresca KP; Joyal JL; Lynch CJ
    Mol Psychiatry; 2011 May; 16(5):569-81. PubMed ID: 20308992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents.
    Albaugh VL; Henry CR; Bello NT; Hajnal A; Lynch SL; Halle B; Lynch CJ
    Obesity (Silver Spring); 2006 Jan; 14(1):36-51. PubMed ID: 16493121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters.
    Davey KJ; O'Mahony SM; Schellekens H; O'Sullivan O; Bienenstock J; Cotter PD; Dinan TG; Cryan JF
    Psychopharmacology (Berl); 2012 May; 221(1):155-69. PubMed ID: 22234378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute peripheral but not central administration of olanzapine induces hyperglycemia associated with hepatic and extra-hepatic insulin resistance.
    Girault EM; Alkemade A; Foppen E; Ackermans MT; Fliers E; Kalsbeek A
    PLoS One; 2012; 7(8):e43244. PubMed ID: 22905238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.
    Cooper GD; Harrold JA; Halford JC; Goudie AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):428-36. PubMed ID: 17933447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities.
    Cooper GD; Pickavance LC; Wilding JP; Harrold JA; Halford JC; Goudie AJ
    J Psychopharmacol; 2007 Jun; 21(4):405-13. PubMed ID: 17050655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive effects of olanzapine and melanin-concentrating hormone agonism on energy balance.
    Guesdon B; Denis RG; Richard D
    Behav Brain Res; 2010 Feb; 207(1):14-20. PubMed ID: 19788900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic treatment with olanzapine via a novel infusion pump induces adiposity in male rats.
    Shobo M; Yamada H; Koakutsu A; Hamada N; Fujii M; Harada K; Ni K; Matsuoka N
    Life Sci; 2011 Apr; 88(17-18):761-5. PubMed ID: 21356217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine increases cell mitotic activity and oligodendrocyte-lineage cells in the hypothalamus.
    Yamauchi T; Tatsumi K; Makinodan M; Kimoto S; Toritsuka M; Okuda H; Kishimoto T; Wanaka A
    Neurochem Int; 2010 Nov; 57(5):565-71. PubMed ID: 20643174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.
    Coccurello R; Caprioli A; Ghirardi O; Conti R; Ciani B; Daniele S; Bartolomucci A; Moles A
    Psychopharmacology (Berl); 2006 Jul; 186(4):561-71. PubMed ID: 16758241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A parametric analysis of olanzapine-induced weight gain in female rats.
    Cooper GD; Pickavance LC; Wilding JP; Halford JC; Goudie AJ
    Psychopharmacology (Berl); 2005 Aug; 181(1):80-9. PubMed ID: 15778884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats.
    Raskind MA; Burke BL; Crites NJ; Tapp AM; Rasmussen DD
    Neuropsychopharmacology; 2007 Feb; 32(2):284-8. PubMed ID: 16710316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine-induced changes in glucose metabolism are independent of the melanin-concentrating hormone system.
    Girault EM; Toonen PW; Eggels L; Foppen E; Ackermans MT; la Fleur SE; Fliers E; Kalsbeek A
    Psychoneuroendocrinology; 2013 Nov; 38(11):2640-6. PubMed ID: 23856185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers.
    Albaugh VL; Singareddy R; Mauger D; Lynch CJ
    PLoS One; 2011; 6(8):e22662. PubMed ID: 21857944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orally disintegrating and oral standard olanzapine tablets similarly elevate the homeostasis model assessment of insulin resistance index and plasma triglyceride levels in 12 healthy men: a randomized crossover study.
    Vidarsdottir S; Vlug P; Roelfsema F; Frölich M; Pijl H
    J Clin Psychiatry; 2010 Sep; 71(9):1205-11. PubMed ID: 20441717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis.
    Graham KA; Perkins DO; Edwards LJ; Barrier RC; Lieberman JA; Harp JB
    Am J Psychiatry; 2005 Jan; 162(1):118-23. PubMed ID: 15625209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.